Trupanion (TRUP) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
2 Mar, 2026Market opportunity and growth
Pet insurance market in North America is large and underpenetrated, with only 3–4% penetration compared to up to 25% in Sweden.
Estimated 180 million cats and dogs in North America, with 120 million visiting veterinarians annually.
Over 1.1 million new pet leads per month, averaging 40 new puppies and kittens per hospital monthly.
Each percentage point increase in insurance penetration represents $1.3 billion in additional revenue.
Pet medical insurance market has grown from $0.9B in 2015 to $5.2B in 2024, a 23% CAGR.
Business model and value proposition
Operates a cost-plus, monthly subscription revenue model with compounding cash flow.
Offers comprehensive, lifelong coverage with no payout limits and covers hereditary/congenital conditions.
Allows freedom to choose any veterinarian and provides direct payment at checkout via proprietary software.
Maintains a 71% claims payout and covers 90% of covered veterinary costs.
Provides 24/7 customer service and leverages significant veterinary hospital experience.
Competitive advantages and moats
Deep, long-standing relationships with veterinarians and direct payment model.
Patented, automated direct veterinary invoice payment system.
Data-driven approach and superior value proposition reinforce defensible market position.
Latest events from Trupanion
- Q1 2026 revenue up 12% to $384M, AOI up 29%, and margins reached record highs.TRUP
Q1 20261 May 2026 - Shareholders will vote on directors, auditor ratification, and executive pay, with strong governance and oversight.TRUP
Proxy filing27 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.TRUP
Proxy filing27 Apr 2026 - Revenue up 12% to $1.44B, net income $19.4M, strong cash flow and subscription growth.TRUP
Q4 20259 Apr 2026 - Strong growth, data-driven innovation, and new products position the company for market expansion.TRUP
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - 2026 guidance highlights pricing-led growth, margin expansion, and broader customer acquisition.TRUP
BofA Securities Animal Health Summit26 Feb 2026 - Q2 2024 revenue up 16%, margins and cash flow improved, and pet retention remained strong.TRUP
Q2 20242 Feb 2026 - Margin expansion, strong retention, and capital surplus drive disciplined growth and innovation.TRUP
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Sustainable growth driven by vet channel, margin recovery, and international expansion.TRUP
Investor Day 202420 Jan 2026